- Home
- / OncoTherapy Science
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
OncoTherapy Science financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
¥33
2024-10-29
Market Capitalization
¥8.7 B
2024-10-29
Revenue
¥808.5 M
FY, 2026
CreditSafe Score
?
Score changed on Jul 11, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| JPY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 | FY, 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 211.3M | 280.6M | 316.2M | 332.5M | 1.2B | 1.1B | 610.1M | 750.0M | 808.5M |
| Cost of goods sold | 326.6M | 263.9M | 1.0B | 1.1B | 787.8M | 762.8M | 794.6M | ||
| Gross profit | 211.3M | 280.6M | (10.4M) | 68.6M | 130.5M | 41.7M | (177.7M) | (12.8M) | 14.0M |
| Gross profit margin, % | 100.0% | 100.0% | -3.3% | 20.6% | 11.3% | 3.7% | -29.1% | -1.7% | 1.7% |
| Operating expense total | 3.1B | 2.8B | 2.1B | 1.7B | 2.2B | 1.1B | 943.1M | 785.2M | 824.3M |
| Depreciation and amortization | 148.7M | 710.5M | 205.7M | 59.8M | 564.3M | 21.6M | 154.6M | 279.0K | 63.2M |
| EBITDA | (2.8B) | (2.6B) | (2.1B) | (1.6B) | (2.0B) | (1.1B) | (1.1B) | (797.9M) | (810.4M) |
| EBITDA margin, % | -1344.3% | -913.0% | -679.9% | -477.9% | -176.5% | -97.5% | -183.7% | -106.4% | -100.2% |
| EBIT | (2.9B) | (3.2B) | (2.2B) | (1.6B) | (2.6B) | (1.1B) | (1.3B) | (795.2M) | (873.0M) |
| EBIT margin, % | -1387.3% | -1136.7% | -708.2% | -468.8% | -221.6% | -96.0% | -208.2% | -106.0% | -108.0% |
| Interest income | 1.1M | 609.0K | 371.0K | 430.0K | 146.0K | ||||
| Interest expense | 218.0K | 1.2M | 1.3M | ||||||
| Pre tax profit | (2.9B) | (3.2B) | (2.2B) | (1.6B) | (2.6B) | (1.1B) | (1.3B) | (813.1M) | (908.5M) |
| Income tax expense | 6.9M | (2.8M) | 1.6M | 1.6M | 1.2M | 2.2M | 2.4M | 2.2M | 2.2M |
| Net Income | (2.9B) | (3.2B) | (2.2B) | (1.6B) | (2.6B) | (1.1B) | (1.3B) | (815.3M) | (910.6M) |